Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Non Operating Income (2016 - 2022)

Historic Non Operating Income for Macrogenics (MGNX) over the last 11 years, with Q4 2022 value amounting to $819000.0.

  • Macrogenics' Non Operating Income rose 28271.03% to $819000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $1.7 million, marking a year-over-year increase of 14411.76%. This contributed to the annual value of $9.4 million for FY2024, which is 273.59% down from last year.
  • As of Q4 2022, Macrogenics' Non Operating Income stood at $819000.0, which was up 28271.03% from $142000.0 recorded in Q3 2022.
  • In the past 5 years, Macrogenics' Non Operating Income ranged from a high of $21.2 million in Q2 2019 and a low of -$6.7 million during Q3 2019
  • Its 5-year average for Non Operating Income is $1.4 million, with a median of $384500.0 in 2020.
  • Data for Macrogenics' Non Operating Income shows a peak YoY increase of 188149.53% (in 2019) and a maximum YoY decrease of 78584.62% (in 2019) over the last 5 years.
  • Quarter analysis of 5 years shows Macrogenics' Non Operating Income stood at -$3.0 million in 2018, then surged by 378.46% to $8.3 million in 2019, then crashed by 99.0% to $83000.0 in 2020, then surged by 157.83% to $214000.0 in 2021, then soared by 282.71% to $819000.0 in 2022.
  • Its Non Operating Income stands at $819000.0 for Q4 2022, versus $142000.0 for Q3 2022 and $504000.0 for Q2 2022.